838 Phenotypic and functional signatures of peripheral and tumor-resident γδ T cells are informative for outcome of checkpoint blockade in melanoma

838 Phenotypic and functional signatures of peripheral and tumor-resident γδ T cells are informative for outcome of checkpoint blockade in melanoma

Bibliographic Details
Main Authors:	Graham Pawelec, Kilian Wistuba-Hamprecht
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Genetic Influence on the Peripheral Differentiation Signature of Vδ2+ γδ and CD4+ αβ T Cells in Adults
by: Nicola Beucke, et al.
Published: (2021-02-01)

Immune Signatures and Survival of Patients With Metastatic Melanoma, Renal Cancer, and Breast Cancer
by: Kilian Wistuba-Hamprecht, et al.
Published: (2020-06-01)

Frequencies of activated T cell populations increase in breast milk of HCMV-seropositive mothers during local HCMV reactivation
by: Katrin Lazar, et al.
Published: (2024-01-01)

Immunomonitoring of Human Breast Milk Cells During HCMV-Reactivation
by: Katrin Lazar, et al.
Published: (2021-09-01)

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade.
by: Jonas Bochem, et al.
Published: (2019-01-01)

Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade
by: Andrea Gaißler, et al.
Published: (2022-07-01)

Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma
by: Teresa Amaral, et al.
Published: (2023-06-01)

Immune Checkpoint Blockade in Melanoma – Earlier is Better?
by: Vincas Urbonas, et al.
Published: (2024-09-01)

Molecular patterns of resistance to immune checkpoint blockade in melanoma
by: Martin Lauss, et al.
Published: (2024-04-01)

Predictive factors of neoadjuvant immune checkpoint blockade in melanoma
by: Melissa Sarver, et al.
Published: (2022-05-01)

Predictors of responses to immune checkpoint blockade in advanced melanoma
by: N. Jacquelot, et al.
Published: (2017-09-01)

838 The role of microbiota in metastatic brain tumors
by: Sarah Johnson, et al.
Published: (2021-11-01)

Dissecting peripheral CD8+ T cell responses and immune interactions during immune checkpoint blockade for metastatic melanoma
by: Tong, O
Published: (2023)

The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
by: Su Yin Lim, et al.
Published: (2023-03-01)

Phenotype and function of peripheral blood γδ T cells in HIV infection with tuberculosis
by: Shi Zou, et al.
Published: (2022-12-01)

Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
by: Frank Riemer, et al.
Published: (2021-09-01)

Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
by: Douglas B. Fox, et al.
Published: (2023-03-01)

Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis
by: Yantao Xu, et al.
Published: (2022-06-01)

Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
by: Beckey Trinh, et al.
Published: (2019-02-01)

Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade
by: Elizabeth I. Buchbinder, et al.
Published: (2021-04-01)

Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy
by: Anastasia Prokopi, et al.
Published: (2021-01-01)

Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
by: Meihua Wang, et al.
Published: (2019-02-01)

Role of Tissue-Resident Memory in Intra-Tumor Heterogeneity and Response to Immune Checkpoint Blockade
by: Kavita M. Dhodapkar
Published: (2018-07-01)

Phenotypic Changes of Peripheral γδ T Cell and Its Subsets in Patients With Coronary Artery Disease
by: Yan Li, et al.
Published: (2022-07-01)

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma
by: Taylor, CA, et al.
Published: (2022)

Overcoming melanoma resistance to immune checkpoint blockade therapy using nano-strategies
by: Yiqin Ding, et al.
Published: (2023-12-01)

Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
by: Xueyan Wang, et al.
Published: (2022-10-01)

Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma
by: Alexander Huang, et al.
Published: (2020-10-01)

Sensitization of ovarian tumor to immune checkpoint blockade by boosting senescence-associated secretory phenotype
by: Xue Hao, et al.
Published: (2021-01-01)

Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer
by: Maximilian Boesch, et al.
Published: (2021-01-01)

B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade
by: Shubhra Singh, et al.
Published: (2022-05-01)

Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma
by: Kimberly Loo, et al.
Published: (2022-01-01)

MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma
by: Ricardo A. de Azevedo, et al.
Published: (2020-01-01)

B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
by: Johannes Griss, et al.
Published: (2019-09-01)

Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma
by: Steven H. Sun, et al.
Published: (2021-10-01)

Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
by: Krista Dubin, et al.
Published: (2016-02-01)

TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
by: Matthew J. Reilley, et al.
Published: (2019-11-01)

Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade
by: Shuming Chen, et al.
Published: (2024-03-01)

Revisit the signatures of γδ T cells in hepatocellular carcinoma
by: Yanan Gao, et al.
Published: (2022-05-01)

Pediatric bacterial meningitis in southern China: analysis of 838 cases
by: Lianfeng Chen, et al.
Published: (2025-02-01)